[HTML] thelancet.comFull View

[HTML][HTML] Early use of low dose tocilizumab in patients with COVID-19: a retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - …, 2020 - thelancet.com
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …
被引用次数：96 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - EClinicalMedicine, 2020 - Elsevier
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …
[HTML] nih.gov

[HTML][HTML] Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - …, 2020 - ncbi.nlm.nih.gov
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …

[引用][C] Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini… - …, 2020 - research.unipd.it

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - 2020 - expeditiorepositorio.utadeo.edu.co
Pneumonia with severe respiratory failure represents the principal cause of death in COVID-
19, where hyper-inflammation plays an important role in lung damage. An effective treatment …

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up.

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - …, 2020 - europepmc.org
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …
[PDF] academia.edu

[PDF][PDF] Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossia, C Scarpazzab, C Filippinia, C Cordiolia… - 2020 - academia.edu
Background: Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini, C Cordioli… - …, 2020 - iris.unibs.it
Background: Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …

Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up

N De Rossi, C Scarpazza, C Filippini… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Pneumonia with severe respiratory failure represents the principal cause of
death in COVID-19, where hyper-inflammation plays an important role in lung damage. An …